Diclofenac Premedication, as the Effect of Preemptive Analgesia After Post-thoracotomy Chest and Shoulder Pain

NCT02445599 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2017-03-09

No results posted yet for this study

Summary

The purpose of the study is to examine if the hyposthesis of the preventive analgestic characteristic of diclofenac given preoperatively has any effect on postoperative thoracic wall and shoulder pain sensation. We also want to examine the rescue analgetic consumption and the postoperative lung function test values.

Conditions

  • Pain
  • Inadequate or Impaired Respiratory Function

Interventions

DRUG

Diclofenac

Orally 100 mg Diclofenac, administered 1 hour before surgery

DRUG

Midazolam

5 mg Dormicum intramuscularly, administered 1 hour before surgery

DRUG

Atropine

0.5 mg Atropine intramuscularly, administered 1 hour before surgery

DRUG

bucain + fentanyl

Via the thocacic epidural cannula 1mg/ml bucain + 5microgr/ml fentanyl solution, with 0.1ml/kg body mass/hour speed is administered.

DRUG

Nalbuphine

1st choice for rescue analgetic 10-20 mg intravenously

DRUG

Diclofenac

2nd choice for rescue analgetic 250ml intravenously

DRUG

Metamizole-sodium

Additional rescue analgetic 2g intravenously

DRUG

Tramadol

Additional rescue analgetic 100mg intravenously

Sponsors & Collaborators

  • University of Debrecen

    lead OTHER

Principal Investigators

  • Béla Fülesdi, MD,PhD,DSci · UNIVERSITY OF DEBRECEN FACULTY OF MEDICINE Department of Anesthesiology and Intensive Care Debrecen, Hungary, 4032

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2016-04-30
Completion
2016-04-30

Countries

  • Hungary

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02445599 on ClinicalTrials.gov